Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05054335 · ClinicalTrials.gov registry record · NA

Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas

A NA study of Pelvic Sarcoma, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT05054335 is a NA study of Pelvic Sarcoma that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05054335, a NA study of Pelvic Sarcoma, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

This trial studies the development of patient-specific computational walking models to improve the surgical planning and rehabilitation treatment of patients with pelvic sarcomas. Every pelvis and pelvic sarcoma are different, and the orthopedic oncologist faces significant challenges when removing a tumor from the complex anatomy of the pelvis. These challenges make it difficult to achieve excellent oncological and functional outcomes together. Computational walking models may be used to predict the best combination of surgical methods and how to implement them to maximize each patient's post-surgery walking function.

Conditions Studied

Interventions

  • OTHER Functional Assessment
  • PROCEDURE X-Ray Imaging

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2019-06-20
Est. Completion 2027-12-21
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT05054335

The ClinicalTrials.gov registry entry for NCT05054335 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Sarcoma appearing as the primary indexed condition, and to 2 interventions - of which Functional Assessment is the first listed.

NCT05054335 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05054335 about?

NCT05054335 is a clinical study titled "Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas". This trial studies the development of patient-specific computational walking models to improve the surgical planning and rehabilitation treatment of patients with pelvic sarcomas. Every pelvis and pelvic sarcoma are different, and the orthopedic oncologist faces significant challenges when removing ...

What is the current status of trial NCT05054335?

This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2019-06-20. Estimated completion is 2027-12-21.

What conditions does trial NCT05054335 study?

This clinical trial studies the following conditions: Pelvic Sarcoma.

What interventions are being tested in trial NCT05054335?

The interventions under investigation include: Functional Assessment (OTHER), X-Ray Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT05054335?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05054335 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.